Gelonghui, April 30 | Jinshi Yayao (300434.SZ) said on the investor interactive platform that currently the application of AI technology in drug development mainly focuses on drug design and optimization, prediction of adverse reactions and clinical trials, and patient recruitment. The company has not yet applied AI technology to drug research and development. The company is actively promoting drug research and development through multiple channels such as independent research and development, outsourced R&D, and document acquisition. Please pay attention to the company's announcements regarding the company's drug development.
- Headlines
- Jinshi Asia Pharmaceutical (300434.SZ): AI technology has not been applied in drug research and development
金石亚药(300434.SZ)：暂未应用AI技术于药物研发
Jinshi Asia Pharmaceutical (300434.SZ): AI technology has not been applied in drug research and development
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Latest
12:03
The Thai SET Index fell by 1% to 1,373.71.
11:54
The Nikkei 226 Index continues to decline, currently down 1.3%, at 39,465.18 points.
11:52
The CEO of Volvo AB Unsponsored ADR Class B stated that the plans for the truck factory in Mexico are still ongoing despite the threats of tariffs from the USA.
VLVLY-0.12%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.